The News
BASF Plant Science acquires Belgian biotechnology company CropDesign.
17/05/2006
BASF´s plant biotechnology company now leading in agronomically important traits to develop higher yielding crops such as corn, soy bean and rape seed.
BASF, the chemical company, and a global leader in agricultural products and fine chemicals, today May 17th, 2006 announced the acquisition of CropDesign.
The Belgian biotech enterprise will become part of BASF Plant Science, BASF´s plant biotechnology company. Both parties agreed not to disclose financial details.
CropDesign´s employees will continue to work at the research facilities in Gent, Belgium, which will become a unit within BASF Plant Science.
The acquisition complements BASF Plant Science´s existing gene discovery activities and extends its leading position in access to agronomical important genetic traits. CropDesign specializes on traits for yield-enhancement, drought tolerance and improved nutrient use efficiency of crops such as corn and rice. Traits are important plant characteristics driven by genes and are the basis of the commercial use of plant biotechnology. BASF Plant Science´s long-term strategy is to develop the next generation plant biotechnology products that offer clear benefits for consumers and the environment.
BASF is convinced that crops with higher yields will become increasingly important to meet the nutritional needs of a growing global population.
“In 15 years we will have close to eight billion people on our planet, almost 1.5 billion more than today. With lead times of 12 to 15 years in research we have no time to lose,” states BASF Board Member Peter Oakley.
In addition, the increasing use of crops as renewable resources such as biofuels or biopolymers will also strain supplies due to the limited availability of suitable land for agriculture.
“CropDesign´s excellent portfolio of important agronomical traits will significantly strengthen our product pipeline of higher yielding crops,” comments Hans Kast, president and CEO of BASF Plant Science. “The screening capacities of CropDesign and the BASF Plant Science Company Metanomics in Berlin offer us both a worldwide unique combination of screening parameters and an extremely high throughput of genes to be tested. This secure us a strong and sustainable competitive advantage to continuously develop our position among the market leaders in plant biotechnology.” “Becoming a part of BASF’s plant biotechnology platform clearly validates the competitive edge of our discovery capabilities and the quality of our trait portfolio. Together we will develop next-generation products for the market,” adds Johan Cardoen, CEO of CropDesign.
Complemented with CropDesign´s important genetic traits based on rice BASF Plant Science further strengthens its unique gene-discovery research. This knowledge based on metabolic profiling has so far been incorporated in Metanomics, where scientists work to identify the metabolic functions of every plant gene, which allows for the development of plants with desired characteristics. The database contains metabolic profiles associated with approximately 30,000 plant genes - knowledge that is already unique to BASF in plant biotech industry.
In December 2005, BASF Plant Science and CropDesign already signed a broad licence and research agreement. The acquisition now secures BASF Plant Science full access to additional traits and to all research and development options of the company that were not yet covered.
About CropDesign
CropDesign is a biotechnology company delivering traits for the global seed market and for plant-based products. CropDesign uses its proprietary TraitMillTM platform to discover genetic traits for the improvement of corn, rice and other plants. Founded in 1998, CropDesign employs more than 70 people at its research facilities in Gent, Belgium and has an extensive network of research and commercial partners. About BASF Plant Science All BASF activities involving plant biotechnology are incorporated in BASF Plant Science. BASF Plant Science coordinates an international research and technology platform with seven sites in four countries in Europe and North America with more than 500 employees. In addition, BASF Plant Science has established numerous complementary co-operations with research institutes, universities and biotechnology companies in Europe and North America. The research activities of BASF Plant Science are concentrated in the areas of more efficient agriculture, healthier nutrition and use of plants for the production of renewable raw materials. These include for example plants with improved tolerance to drought.
Another research focus is to develop plants with a higher level of vitamins or with omega-3-fatty acids that can prevent cardiovascular diseases. Within the next three years BASF will invest €270 million in the expansion of its plant biotechnology operations. BASF is the world’s leading chemical company: The Chemical Company. In 2005, BASF had approximately 81,000 employees and posted sales of approximately € 42,7 billion. To find out more about BASF Plant Science, please see our web site at: http://www.basf.com/biotechnology
Note to editors: press photos can also be downloaded at www.basf.de/pressphotos under the heading biotechnology.
2006
-
18/01/2006
Ablynx announces pharma alliance to develop therapeutic Nanobodies™
-
23/01/2006
Sofinnova et Apax Partners investissent 12 millions d'euros dans DBV Technologies
-
23/01/2006
Sofinnova and Apax Partners invest €12 million in DBV Technologies
- 24/01/2006
-
24/01/2006
Emailvision files for an IPO on the Euronext Paris Alternext stock market.
-
24/01/2006
Varioptic announces general availability of the Artic 320 liquid lens for camera-phones
- 24/01/2006
- 24/01/2006
- 31/01/2006
- 03/02/2006
-
03/02/2006
Sofinnova Partners takes two prizes in prestigious EVJC awards event
-
03/02/2006
La richesse et les performances Java d’Esmertec à présent disponibles sur AJAR de TTPCom
- 03/02/2006
-
08/02/2006
Emailvision Announces Successful IPO On Euronext Paris Alternext Market.
- 08/02/2006
-
13/02/2006
Lectus Therapeutics closes Series A funding round raising £8.2 million
- 15/02/2006
-
01/03/2006
CoreValve names J. C. MacRae as Vice President of Finance and Chief Financial Officer
-
28/02/2006
Faust Pharmaceuticals nomme Thomas C. Seoh au poste de directeur général
-
02/03/2006
NicOx conclut un nouvel accord majeur avec Pfizer pour des composés donneurs de NO en ophtalmologie
-
02/03/2006
NicOx signs major new agreement with Pfizer for NOdonating compounds in ophthalmology
- 09/03/2006
- 14/03/2006
- 14/03/2006
-
14/03/2006
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
- 24/03/2006
- 27/03/2006
- 28/03/2006
-
28/03/2006
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
-
24/03/2006
Esmertec apporte au marché M2M une solution logicielle client-serveur unique – OSVM Universe
- 28/03/2006
-
10/04/2006
Endoart SA Completes US$ 10.5 million (CHF 13.5 million) Venture Financing Round
- 26/04/2006
-
26/04/2006
Endoart's remote-controlled gastric band gets .5m injection of private money
- 19/04/2006
-
02/05/2006
Barrett Katz, MD, MBA, Appointed EVP & CMO of Fovea Pharmaceuticals
- 27/04/2006
- 27/04/2006
-
25/04/2006
Varioptic lève 16.4 millions d’euros ($20m) pour son troisième tour de table
-
25/04/2006
Varioptic Secures € 16.4 million (USD 20m) in Third Round of Financing
-
19/04/2006
Fidelity Investments International acquiert près de 10% du capital d’Emailvision
- 04/05/2006
- 04/05/2006
-
03/05/2006
Cotherix Inc. : Net Sales Increase 32 Percent Over Previous Quarter
- 10/05/2006
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
- 11/05/2006
- 09/05/2006
- 11/05/2006
- 15/06/2006
- 15/05/2006
- 02/05/2006
-
10/05/2006
Samsung selects 6Wind software to develop mobile IP applications
-
10/05/2006
Samsung selectionne 6Wind pour développer des applications de mobilité IP
- 17/05/2006
- 18/05/2006
- 16/05/2006
- 03/05/2006
- 18/05/2006
-
18/05/2006
Prévision d'une baisse importante du chiffre d'affaires au premier semestre 2006
-
17/05/2006
BASF Plant Science acquires Belgian biotechnology company CropDesign.
- 29/05/2006
-
11/05/2006
Diatos Annonce l’Acquisition du Médicament Oncologique DaunoXome® auprès de Gilead Sciences
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
-
06/06/2006
Varioptic finalise son tour de table avec la participation de Dow Corporate Venture Capital
- 06/06/2006
- 13/06/2006
-
15/05/2006
UPEK Recognized as 2006 Laureate by The Computerworld Honors Program
- 19/06/2006
- 28/06/2006
- 08/06/2006
-
07/07/2006
Varioptic etend sa gamme de solutions autofocus avec Artic 416
- 06/07/2006
- 02/08/2006
- 02/08/2006
- 17/07/2006
- 17/07/2006
- 29/08/2006
-
28/08/2006
Travel Meta Search receives financing round from Sofinnova Partners and Walden International
-
30/08/2006
Esmertec announces results for the half-year ended June 30, 2006
-
30/08/2006
Addex commences Phase II clinical trials programme with ADX10059
- 05/09/2006
- 23/08/2006
- 23/08/2006
- 11/09/2006
- 11/09/2006
- 11/09/2006
- 26/09/2006
- 05/10/2006
-
05/10/2006
WYPLAY SAS reçoit un financement de 4 millions d’euros de la part de Sofinnova Partners
-
05/10/2006
WYPLAY SAS receives €4 million financing round from Sofinnova Partners
- 09/10/2006
- 09/10/2006
-
09/10/2006
Esmertec annonce la cession de sa participation majoritaire dans sa filiale japonaise
-
09/10/2006
Esmertec Announces Sale of Majority Stake in Japanese Subsidiary
- 10/10/2006
- 10/10/2006
- 10/10/2006
-
17/10/2006
Inside Contactless selected as finalist to receive cartes 2006 Best Hardware sesame award
- 19/10/2006
-
16/10/2006
UPEK Receives First FIPS 201 Certification for Silicon Fingerprint Sensors
- 20/10/2006
- 20/10/2006
-
18/10/2006
VoluBill signs new deal with major mobile operator in Northern Africa
- 24/10/2006
- 24/10/2006
-
24/10/2006
Corevalve's 18-french revalving™ system demonstrated 'live' at TCT 2006
-
02/11/2006
Launch of Blyk Heralds a New Opportunity in Mobile Advertising
- 06/11/2006
- 06/11/2006
- 13/11/2006
-
13/11/2006
Cerenis Therapeutics clôt un tour de financement record de 42.1 millions d'euros
- 13/11/2006
-
13/11/2006
Initial Clinical Experience with Telemetrically Adjustable Gastric Banding
- 21/11/2006
- 21/11/2006
-
30/11/2006
Esmertec’s Jbed Software Deployed in LG Electronics’ Highly Successful GSM-based Chocolate Phone
-
05/12/2006
Esmertec and Yuhua TelTech Set New Benchmark with 1-stop Solution for Linux®-Based Mobile Devices
- 21/12/2006
- 22/02/2006
-
21/02/2006
Stentys appoints Luc Morisset as Director of Regulatory Affairs
- 28/02/2006